AstraZeneca Is Said to Have Explored Bristol Myers Merger
Share
AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It's unclear if discussions are ongoing or whether they will result in a transaction, the people cautioned. A representative for AstraZeneca declined to comment and Bristol Myers Squibb couldn't immediately be reached for comment on the talks. Bloomberg's Manuel Baigorri reports.